Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
NSCLC
Pharma
BMS' Opdivo widens lung cancer reach with perioperative FDA nod
The PD-1/L1 inhibitor is now cleared to treat certain non-small cell lung cancer patients before and after surgery.
Zoey Becker
Oct 3, 2024 3:54pm
FDA's ODAC calls for revamp of perioperative NSCLC trials
Jul 25, 2024 5:00pm
Boehringer Ingelheim preps for 2 upcoming oncology launches
Jun 10, 2024 8:20am
Summit and Akeso deliver Keytruda-topping results in NSCLC
May 31, 2024 11:00am
Keytruda catches up with Opdivo in rare lung cancer type
Mar 10, 2023 10:00am
Merck doesn't expect immediate boost from Keytruda's last nod: CEO
Feb 2, 2023 11:24am
